FabRx announces launch of M3DIMAKER
FabRx Ltd., the innovative pharmaceutical biotechnology spin-out from University College London (UCL) pioneering 3D printing of pharmaceuticals, has released the first pharmaceutical 3D printer M3DIMAKER for the manufacture of personalised medicines. FabRx is thrilled to announce that their cutting edge alternating nozzle 3D printing system, which has been tested in hospitals, pharmacies and research institutes around the world, has now been launched onto the market.
Continue reading “FabRx announces launch of M3DIMAKER, first pharmaceutical 3D printer for manufacturing personalised medicines”
Usually when we think about the medicine, vitamins and supplements that we take in pill and tablet form, one or two common shapes come to mind: in most cases it’s either an elongated oval/spherical form or a simple extruded circle. Continue reading “Pharmaceutical researchers create new shapes for medicine tablets using 3D printing”
Rainbow Coral Corp. and Nano3D Biosciences (n3D) are lining up new 3D bioprinting opportunities and potential partnerships following a highly successful product exhibition last month at Biotech Showcase 2015 in San Francisco. Continue reading “Rainbow Coral and Nano3D Biosciences Pursue New 3D Bioprinting Opportunities, Partnerships”
It has been announced, that a novel application of 3D-Bioprinting living tissue models for pharmaceutical testing is being developed at Swansea University-UK. A team of scientists have begun trailing a process, which has been designed to augment the development of new drugs and treatments. Continue reading “Swansea University Scientists Engineer 3D Bioprinted Tissues for Pharmaceutical Research”